Accessibility Menu
AlloVir logo

AlloVir

(NASDAQ) ALVR

This security has been delisted. This page is retained for historical reference.

AlloVir last closing stock price
MetricPriceDate
Last closeUSD 4.822026-07-15
AlloVir stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.34%USD 4.712026-07-08
1 month+12.88%USD 4.272026-06-15
3 month-26.86%USD 6.592026-04-16
Year to date-42.89%USD 8.442025-12-31
1 year+100.83%USD 2.402025-07-15
3 year-94.01%USD 80.502023-07-14
5 year-98.81%USD 405.492021-07-16
Since inception-98.32%USD 583.972020-07-30

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ALVR Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-72.78%

Return on Capital

-57.50%

Return on Assets

-40.16%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$47.63M

EBITDA

-$46.78M

Operating Cash Flow

-$42.51M

Capital Expenditure

-$200.00K

Free Cash Flow

-$42.71M

Cash & ST Invst.

$97.22M

Total Debt

$1.41M

AlloVir Performance Analysis

AlloVir annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
AlloVir sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
AlloVir annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -50.62-19.6%
20232023-12-31USD -42.09-16.9%
20242024-12-31USD -51.7723.0%
20252025-12-31USD -2.85-94.5%
AlloVir sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30-4.9%
Q42025-12-31-150.0%
Q12026-03-3171.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

6

N/A

Net Income

-$10.86M

N/A

EBITDA

-$11.83M

-14.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$97.22M

-3.7%

Total Debt

$1.41M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.09M

N/A

Short Term Debt

$317.00K

N/A

Return on Assets

-40.16%

N/A

Return on Invested Capital

-46.82%

N/A

Free Cash Flow

-$11.58M

-55.6%

Operating Cash Flow

-$11.58M

-55.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KRONKronos Bio, Inc.
$0.88+1.49%
BLUEbluebird bio, Inc.
$4.97+0.00%
SYRESpyre Therapeutics, Inc.
$94.12-7.79%
RNTXRein Therapeutics Inc.
$0.86-8.90%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.